Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Establishing a Multicenter Longitudinal Clinical Cohort Study in Ethiopia: Advanced Clinical Monitoring of Antiretroviral Treatment Project.

Teklu AM, Tsegaye E, Fekade D, Hailemelak A, Weiss W, Hassen E, Simmons N, Zewdu S, Berhan Y, Getachew A, Hagos T, Alebachew A, Damena M, Sitotaw Y, Assefa Y, Medhin G, Ruff A.

Ethiop J Health Sci. 2017 Feb;27(Suppl 1):3-16.

2.

Associations Between Khat Use and HIV Risk and Status Among Voluntary Counseling and Testing Center Clients in Addis Ababa, Ethiopia.

Berhanu D, Diener-West M, Ruff A, Davis WW, Celentano DD, Go VF.

J Addict Med. 2017 Mar 28. doi: 10.1097/ADM.0000000000000304. [Epub ahead of print]

PMID:
28353466
3.

Cohort profile: improving treatment of HIV-infected Ethiopian children through better detection of treatment failure in southern Ethiopia.

Tadesse BT, Foster BA, Jerene D, Ruff A.

BMJ Open. 2017 Feb 28;7(2):e013528. doi: 10.1136/bmjopen-2016-013528.

4.

Cost-effectiveness of Diagnostic Algorithms for Tuberculosis in Children Less Than 5 Years of Age.

Debes AK, Gilman RH, Onyango-Makumbi C, Ruff A, Oberhelman R, Dowdy DW.

Pediatr Infect Dis J. 2017 Jan;36(1):36-43.

PMID:
27749648
5.

Predictors of Infant Age at Enrollment in Early Infant Diagnosis Services in Kenya.

Goggin K, Wexler C, Nazir N, Staggs VS, Gautney B, Okoth V, Khamadi SA, Ruff A, Sweat M, Cheng AL, Finocchario-Kessler S.

AIDS Behav. 2016 Sep;20(9):2141-50. doi: 10.1007/s10461-016-1404-z.

6.

Improving early infant HIV diagnosis in Kenya: study protocol of a cluster-randomized efficacy trial of the HITSystem.

Finocchario-Kessler S, Goggin K, Khamadi S, Gautney B, Dariotis JK, Bawcom C, Cheng AL, Nazir N, Martin C, Ruff A, Sweat M, Okoth V.

Implement Sci. 2015 Jul 9;10:96. doi: 10.1186/s13012-015-0284-3.

7.

Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.

Yirdaw KD, Jerene D, Gashu Z, Edginton ME, Kumar AM, Letamo Y, Feleke B, Teklu AM, Zewdu S, Weiss B, Ruff A.

PLoS One. 2014 Aug 8;9(8):e104557. doi: 10.1371/journal.pone.0104557. eCollection 2014.

8.

Collaboratively reframing mental health for integration of HIV care in Ethiopia.

Wissow LS, Tegegn T, Asheber K, McNabb M, Weldegebreal T, Jerene D, Ruff A.

Health Policy Plan. 2015 Jul;30(6):791-803. doi: 10.1093/heapol/czu058. Epub 2014 Jul 10.

9.

Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.

Hudgens MG, Taha TE, Omer SB, Jamieson DJ, Lee H, Mofenson LM, Chasela C, Kourtis AP, Kumwenda N, Ruff A, Bedri A, Jackson JB, Musoke P, Bollinger RC, Gupte N, Thigpen MC, Taylor A, van der Horst C.

Clin Infect Dis. 2013 Jan;56(1):131-9. doi: 10.1093/cid/cis808. Epub 2012 Sep 20.

10.

Khat use among HIV voluntary counselling and testing centre clients in Ethiopia.

Berhanu D, Go VF, Ruff A, Celentano DD, Bishaw T.

Cult Health Sex. 2012;14(10):1197-212. doi: 10.1080/13691058.2012.722684. Epub 2012 Sep 18.

PMID:
22988913
11.

PEPFAR scale-up of pediatric HIV services: innovations, achievements, and challenges.

Abrams EJ, Simonds RJ, Modi S, Rivadeneira E, Vaz P, Kankasa C, Tindyebwa D, Phelps BR, Bowsky S, Teasdale CA, Koumans E, Ruff AJ.

J Acquir Immune Defic Syndr. 2012 Aug 15;60 Suppl 3:S105-12. doi: 10.1097/QAI.0b013e31825cf4f5. Review.

12.

Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings.

Ziemniak C, Mengistu Y, Ruff A, Chen YH, Khaki L, Bedri A, Simen BB, Palumbo P, Eshleman SH, Persaud D.

J Clin Microbiol. 2011 Dec;49(12):4077-82. doi: 10.1128/JCM.01004-11. Epub 2011 Sep 28.

13.

Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.

Persaud D, Bedri A, Ziemniak C, Moorthy A, Gudetta B, Abashawl A, Mengistu Y, Omer SB, Isehak A, Kumbi S, Adamu R, Lulseged S, Ashworth R, Hassen E, Ruff A; Ethiopian Swen Study Team.

AIDS Res Hum Retroviruses. 2011 Aug;27(8):823-9. doi: 10.1089/AID.2010.0346. Epub 2011 Feb 25.

14.

Predictive value of weight loss on mortality of HIV-positive mothers in a prolonged breastfeeding setting.

Koyanagi A, Humphrey JH, Moulton LH, Ntozini R, Mutasa K, Iliff P, Ruff AJ; Zvitambo Study Group.

AIDS Res Hum Retroviruses. 2011 Nov;27(11):1141-8. doi: 10.1089/AID.2010.0293. Epub 2011 Feb 16.

15.

Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy.

Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, Mutasa K, Ruff A, Ward B; ZVITAMBO Study Group.

Pediatr Infect Dis J. 2011 Jan;30(1):45-51. doi: 10.1097/INF.0b013e3181ecbf7e.

PMID:
21173675
16.

Postpartum plasma CD4 change in HIV-positive women: implications for timing of HAART initiation.

Koyanagi A, Ruff AJ, Moulton LH, Ntozini R, Mutasa K, Iliff P, Humphrey JH; ZVITAMBO Study Group.

AIDS Res Hum Retroviruses. 2010 May;26(5):547-52. doi: 10.1089/aid.2009.0138.

17.

Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.

Six Week Extended-Dose Nevirapine (SWEN) Study Team, Bedri A, Gudetta B, Isehak A, Kumbi S, Lulseged S, Mengistu Y, Bhore AV, Bhosale R, Varadhrajan V, Gupte N, Sastry J, Suryavanshi N, Tripathy S, Mmiro F, Mubiru M, Onyango C, Taylor A, Musoke P, Nakabiito C, Abashawl A, Adamu R, Antelman G, Bollinger RC, Bright P, Chaudhary MA, Coberly J, Guay L, Fowler MG, Gupta A, Hassen E, Jackson JB, Moulton LH, Nayak U, Omer SB, Propper L, Ram M, Rexroad V, Ruff AJ, Shankar A, Zwerski S.

Lancet. 2008 Jul 26;372(9635):300-13. doi: 10.1016/S0140-6736(08)61114-9.

PMID:
18657709
18.

Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality.

Humphrey JH, Iliff PJ, Marinda ET, Mutasa K, Moulton LH, Chidawanyika H, Ward BJ, Nathoo KJ, Malaba LC, Zijenah LS, Zvandasara P, Ntozini R, Mzengeza F, Mahomva AI, Ruff AJ, Mbizvo MT, Zunguza CD; ZVITAMBO Study Group.

J Infect Dis. 2006 Mar 15;193(6):860-71. Epub 2006 Feb 8. Erratum in: J Infect Dis. 2008 May 15;197(10):1485.

PMID:
16479521
19.

Pseudomonas aeruginosa pre-septal cellulitis and bacteremia in a pediatric oncology patient.

Milstone AM, Ruff AJ, Yeamans C, Higman MA.

Pediatr Blood Cancer. 2005 Sep;45(3):353; discussion 354. No abstract available.

PMID:
15926173
20.

Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials.

Gaillard P, Fowler MG, Dabis F, Coovadia H, Van Der Horst C, Van Rompay K, Ruff A, Taha T, Thomas T, De Vincenzi I, Newell ML; Ghent IAS Working Group on HIV in Women and Children.

J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):178-87. Review.

PMID:
14722452

Supplemental Content

Loading ...
Support Center